What can we expect from liposomal drugs?
Dumontet
C
C
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage* / Q000009:adverse effects; D016503:Drug Delivery Systems; D006801:Humans; D008081:Liposomes; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D008081:Liposomes; D003630:Daunorubicin